The presence of ICAM-1 in the neutrophil-rich region (Figure 2a) suggests that, early after induction of immunogenic cell death (day 3 of panobinostat exposure), the neutrophils are anti-tumor, N1-polarized, and possibly licensed. The gene discussed is ICAM1; the disease is neoplasm.